Satsuma Pharmaceuticals Probability of Future Stock Price Finishing Under 1.08
| STSADelisted Stock | USD 1.10 0.01 0.90% |
Satsuma |
Satsuma Pharmaceuticals Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of Satsuma Pharmaceuticals for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for Satsuma Pharmaceuticals can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| Satsuma Pharmaceuticals is not yet fully synchronised with the market data | |
| Satsuma Pharmaceuticals may become a speculative penny stock | |
| Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors |
Satsuma Pharmaceuticals Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of Satsuma Stock often depends not only on the future outlook of the current and potential Satsuma Pharmaceuticals' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. Satsuma Pharmaceuticals' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 32 M | |
| Cash And Short Term Investments | 52.5 M |
Satsuma Pharmaceuticals Technical Analysis
Satsuma Pharmaceuticals' future price can be derived by breaking down and analyzing its technical indicators over time. Satsuma Stock technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of Satsuma Pharmaceuticals. In general, you should focus on analyzing Satsuma Stock price patterns and their correlations with different microeconomic environments and drivers.
Satsuma Pharmaceuticals Predictive Forecast Models
Satsuma Pharmaceuticals' time-series forecasting models is one of many Satsuma Pharmaceuticals' stock analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary Satsuma Pharmaceuticals' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the stock market movement and maximize returns from investment trading.
Things to note about Satsuma Pharmaceuticals
Checking the ongoing alerts about Satsuma Pharmaceuticals for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for Satsuma Pharmaceuticals help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| Satsuma Pharmaceuticals is not yet fully synchronised with the market data | |
| Satsuma Pharmaceuticals may become a speculative penny stock | |
| Satsuma Pharmaceuticals has a very high chance of going through financial distress in the upcoming years | |
| Net Loss for the year was (70.06 M) with profit before overhead, payroll, taxes, and interest of 0. | |
| Satsuma Pharmaceuticals currently holds about 68.06 M in cash with (51.52 M) of positive cash flow from operations. This results in cash-per-share (CPS) ratio of 2.15, which can makes it an attractive takeover target, given it will continue generating positive cash flow. | |
| Roughly 58.0% of the company shares are owned by institutional investors |
Check out World Market Map to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in state. You can also try the Latest Portfolios module to quick portfolio dashboard that showcases your latest portfolios.
Other Consideration for investing in Satsuma Stock
If you are still planning to invest in Satsuma Pharmaceuticals check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the Satsuma Pharmaceuticals' history and understand the potential risks before investing.
| Odds Of Bankruptcy Get analysis of equity chance of financial distress in the next 2 years | |
| Earnings Calls Check upcoming earnings announcements updated hourly across public exchanges | |
| Latest Portfolios Quick portfolio dashboard that showcases your latest portfolios | |
| Money Managers Screen money managers from public funds and ETFs managed around the world | |
| Share Portfolio Track or share privately all of your investments from the convenience of any device |